Lupin, a pharmaceutical research company headquartered in India, will expand in Coral Springs, creating at least 45 high-skilled positions.
The company said Friday that it also plans to open a new laboratory by the end of this year.
Lupin’s new research center will focus on development of drugs for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases.
BusinessWarren Buffett buys auto group, boosts competition for AutoNationSee all related
Xian-Ming Zeng, senior vice president of inhalation research and development for Lupin, said the ability to recruit top scientists in South Florida was a factor in locating the research center in Broward.
Bob Swindell, president of the Greater Fort Lauderdale Alliance, said the company’s decision to grow in Coral Springs is a “testament to the strength of the pharmaceutical industry in Broward County.
Florida is home to nearly 1,000 biotech, pharmaceutical and medical devices companies, and more than 44,000 health-care establishments, the Alliance said.
Lupin is a U.S. owned subsidiary of Lupin Limited, a research-oriented pharmaceutical company headquartered in Mumbai, India.
email@example.com or 561-243-6650
Copyright © 2014, Sun Sentinel